MSB 2.29% $1.07 mesoblast limited

The FDA’s focus is thus far on tests and devices rather than the...

  1. 280 Posts.
    lightbulb Created with Sketch. 311
    The FDA’s focus is thus far on tests and devices rather than the condition.

    https://www.optometrytimes.com/view/fda-clears-the-first-early-detection-sepsis-test-in-emergency-department-focused-diagnostic-tools

    https://ambientclinical.com/2022/10/31/newly-released-fda-guidelines-sepsis-detection-means-hospitals/#:~:text=With%20this%20guidance%2C%20EHR%20companies,without%20obtaining%20FDA%20clearance%20first.
    Last edited by irenekwshiu: 20/03/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.025(2.29%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.10 $1.10 $1.06 $4.942M 4.613M

Buyers (Bids)

No. Vol. Price($)
6 70659 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 43531 2
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.